ReviewJournal of molecular medicine (Berlin, Germany)2008
Antimicrobial mechanisms of the urinary tract.
Review in Journal of molecular medicine (Berlin, Germany), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Innate immune functions of bitter taste receptors across physiological systems.Journal of translational medicine · 2026Review
- Immunomodulation therapy offers new molecular strategies to treat UTI.Nature reviews. Urology · 2022Review
- Molecular determinants of disease severity in urinary tract infection.Nature reviews. Urology · 2021Review
- Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates.MicrobiologyOpen · 2019Article
- Encrustations on ureteral stents from patients without urinary tract infection reveal distinct urotypes and a low bacterial load.Microbiome · 2019Article
- Psoriasin, a novel anti-Candida albicans adhesin.Journal of molecular medicine (Berlin, Germany) · 2018Article
- The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.BMC infectious diseases · 2018Article
- Article
- Article
- The role of the antimicrobial peptide cathelicidin in renal diseases.Pediatric nephrology (Berlin, Germany) · 2015Review
- Article
- Kidney α-intercalated cells and lipocalin 2: defending the urinary tract.The Journal of clinical investigation · 2014Article
- Peeing pentraxins.Immunity · 2014Article
- "Click" immobilization on alkylated silicon substrates: model for the study of surface bound antimicrobial peptides.Chemistry (Weinheim an der Bergstrasse, Germany) · 2011Article
- Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.PloS one · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The urinary tract is a key system to maintain the homeostasis of the human body. It is relatively open to the outside environment, the perineum, a region highly colonized by bacteria. Bacteria can even be found in urine of healthy individuals. Still, urinary tract infections are far less frequent than it could be expected under these conditions. The high resistance against such infections has been observed already more than 100 years ago. Since then, many antimicrobial mechanisms of the urinary tract have been elucidated. Some questions, however, remain challenges for patients, scientists and health care professionals. In this review, we try to summarize the achieved knowledge about mechanisms, maintaining the urinary tract free of infection. In addition, we discuss their relevance and possible clinical application.
Indexed as
Identifiers
17805504What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.